Search clinical trials for: Concurrent Chemoradiotherapy Radiotherapy

Total 3486 results

Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

The Study of Envafolimab Combined With Concurrent Chemoradiotherapy In LS-SCLC

Lung Neoplasms
Cancer Institute and Hospital, Chinese Academy...

Unknown

IORT Followed by CCRT or SBRT for Locally Advanced Pancreatic Cancer (IFCSLAPC)

Pancreatic Cancer

China
Cancer Institute and Hospital, Chinese Academy...
Zhejiang Cancer Hospital; Sun Yat-sen University; Fudan University; West China... and other collaborators

Unknown

Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC

Lung Neoplasms | Carcinoma, Small Cell

China
Ruijin Hospital

Recruiting

Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients

Cervical Cancer

China
Zhejiang Cancer Hospital

Unknown

Concurrent Chemotherapy for Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Eye & ENT Hospital of Fudan University
Changhai Hospital; Fudan University; RenJi Hospital; Xinhua Hospital, Shanghai... and other collaborators

Recruiting

Clinical Treatments in Specialized Disease of Laryngeal Carcinoma (LC) and Hypopharyngeal Carcinoma (HPC)

Glottic Carcinoma | Supraglottic Carcinoma | Subglottic Carcinoma | Pyriform Sinus Carcinoma | Postcricoid Carcinoma | Posterior Pharyngeal Wall Carcinoma

China
Sun Yat-sen University

Active, not recruiting

Hypofractionated Chemoradiotherapy and Thymosin α1 in Unresectable or Recurrent Thymic Epithelial Tumor

Thymoma and Thymic Carcinoma

China
Shanghai General Hospital, Shanghai Jiao Tong University...

Completed

PET/CT-directed Hyperfractionated Radiation Dose Escalation in Stage III Non-small Cell Lung Cancer

Non Small Cell Lung Cancer

China
Sun Yat-sen University

Withdrawn

Evaluating Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy Followed by Consolidation Immunotherapy for Locally Advanced Non-small Cell Lung Cancer

Efficacy and Safety | Locally Advanced Non-small Cell Lung Cancer

China
Guizhou Provincial People's Hospital

Recruiting

Study on the Relationship Between Plasma MRD and cfDNA HPV and the Efficacy and Prognosis of Locally Advanced Cervical Cancer After Concurrent Chemoradiotherapy

Locally Advanced Cervical Cancer

China
Shanghai General Hospital, Shanghai Jiao Tong University...

Completed

PET/CT-directed Hyperfractionated Radiation Dose Escalation in Esophageal Cancer

Esophageal Cancer

China
Tianjin Medical University Cancer Institute and...

Not yet recruiting

Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC.

Esophageal Cancer

China
Nanfang Hospital of Southern Medical University

Recruiting

Cisplatin-based and Carboplatin-based Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma

Cisplatin | NPC | Carboplatin

China
Fudan University

Not yet recruiting

The Efficacy and Safety of Cadonilimab (AK104) as Induction and Consolidation Therapy for Locally Advanced/Unresectable NSCLC Patients Receiving Concurrent Chemoradiotherapy

NSCLC | Locally Advanced Lung Carcinoma

China
Second Affiliated Hospital, School of Medicine,...

Unknown

A Multicenter, Prospective, Phase III Randomized Controlled Clinical Study for the Treatment of N2-3 Nasopharyngeal Carcinoma Patients

Nasopharyngeal Carcinoma | Neoadjuvant Chemotherapy

China
State Scientific Centre of Coloproctology, Russian...

Recruiting

Total Neoadjuvant Therapy in Rectal Cancer Treatment

Rectal Cancer

Russian Federation
Betta Pharmaceuticals Co., Ltd.

Unknown

Icotinib With Concurrent Radiotherapy Versus Chemotherapy With Concurrent Radiotherapy in Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Tianjin Medical University Cancer Institute and...

Recruiting

Toripalimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer

Cervical Cancer

China
Shanghai Chest Hospital

Recruiting

Accelerated Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LS-SCLC

SCLC

China
Eye & ENT Hospital of Fudan University
Peking University Third Hospital; Zhongshan Ophthalmic Center, Sun Yat-sen... and other collaborators

Recruiting

Neoadjuvant Radiotherapy for Malignant Lacrimal Sac Tumors

Malignant Tumor of Lacrimal Drainage Structure

China
First Affiliated Hospital of Guangxi Medical University

Recruiting

Tislelizumab Combined With Concurrent Chemoradiotherapy as First-line Treatment for Stage IIIC2 Cervical Cancer

Cervical Cancer

China
Shandong Cancer Hospital and Institute

Unknown

Concurrent Chemoradiotherapy Combination With Anlotinib for Unresectable Stage III NSCLC Patients

Carcinoma, Non-Small-Cell Lung

China
Tata Memorial Hospital
Ministry of Science and Technology, India

Terminated

Concurrent Chemoradiation Versus Surgery With Adjuvant Therapy in Advanced Laryngopharyngeal Cancers

Larynx Neoplasms

India
Tianjin Medical University Cancer Institute and...

Recruiting

Concurrent Chemoradiotherapy Combination With Anlotinib for Limited-stage Small Cell Lung Cancer

Small Cell Lung Cancer Limited Stage

China
Sun Yat-sen University

Completed

Percutaneous Endoscopic Gastrostomy Before Definitive Concurrent Chemoradiation Therapy for Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

China
Samsung Medical Center

Completed

Adjuvant CCRT vs CT in Minimal N2 NSCLC

Non-small Cell Lung Cancer

Korea, Republic of
JIANYANG WANG
Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Recruiting

The Effect of Prophylactic TPO Combined With BMS-IMRT to Esophageal Cancer Patients

Esophageal Cancer | Thrombocytopenia | Concurrent Chemoradiotherapy | Intensity-modulated Radiation Therapy

China
Lei Li

Recruiting

PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer

Cervical Carcinoma | Immunotherapy | Survival Outcomes | Adverse Events | Locally Advanced Cervical Cancer | Chemoradiotherapy | Immune Checkpoint Inhibitor | Anti-programmed Cell Death Receptor 1 | Early Stage Cervical Cancer

China
Jing Jin, M.D.

Recruiting

A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk

Rectal Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Completed

Report of the Survival Outcomes of Patients With Esophageal Cancer After Definitive Radiotherapy in China

Esophageal Neoplasms

China
Sun Yat-sen University
Wuzhou Red Cross Hospital; Fifth Affiliated Hospital, Sun Yat-Sen University; Affiliated Cancer Hospital & Institute of Guangzhou Medical University and other collaborators

Recruiting

Toripalimab Plus Concurrent Chemo-radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma | Chemotherapy | Radiotherapy | PD-1 Treatment

China
The First Affiliated Hospital of Henan University...
Jiangsu HengRui Medicine Co., Ltd.; Anyang Tumor Hospital; 150th Hospital of PLA

Unknown

Chemoradiation Versus Esophagectomy for Locally Advanced Esophageal Cancer (CELAEC)

Esophagus Cancer

China
Tata Memorial Hospital

Unknown

Oral Cancer Adjuvant Therapy (OCAT) Trial

Mouth Neoplasms

India
Cancer Institute and Hospital, Chinese Academy...
Xijing Hospital; Peking Union Medical College Hospital; Peking University Cancer... and other collaborators

Active, not recruiting

A Study of Total Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer

Rectal Cancer

China
Celgene
BeiGene

Terminated

A Study of Tislelizumab (BGB-A317) Plus Chemoradiotherapy Followed by Tislelizumab Monotherapy in Newly Diagnosed, Stage III Subjects With Locally Advanced, Unresectable Non-small Cell Lung Cancer (RATIONALE001)

Carcinoma, Non-Small-Cell Lung

Spain, United States, Japan, China, Canada, United Kingdom, Belgium, Singapore, Korea, Republic of, Netherlands, France, Romania, Greece, Germany, Taiwan, Finland, Italy, Poland, Hungary, Ireland, Portugal, New Zealand, Russian Federation
Maastricht Radiation Oncology

Completed

Adaptive Radiotherapy in Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer

Netherlands
Shandong Cancer Hospital and Institute

Terminated

A Trial of Anlotinib Combined With Concurrent Chemoradiotherapy in Patients With Unresectable Stage III Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Mianyang Central Hospital

Unknown

S-1 IMRT Versus S-1 and Cisplatin Concurrent IMRT in Inoperable Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

China
Barretos Cancer Hospital

Completed

Induction Chemotherapy for Advanced Head and Neck Cancer

Head and Neck Cancer

Brazil
Sixth Affiliated Hospital, Sun Yat-sen University

Recruiting

Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients

Anal Canal Cancer | Anal Squamous Cell Carcinoma | Anal Cancer | Anal Canal Cancer Stage III

China
West China Hospital

Recruiting

Total Neoadjuvant Treatment vs. Chemoradiotherapy in Local Advanced Rectal Cancer With High Risk Factors (TNTCRT)

Chemoradiotherapy | Total Neoadjuvant Treatment | Local Advanced Rectal Cancer | High Risk Factors

China
Capital Medical University

Completed

Concurrent Chemoradiation With or Without DC-CIK Immunotherapy in Treating Locally Advanced Esophageal Cancer

Esophageal Carcinoma

China
Clinica Universidad de Navarra, Universidad de...

Completed

Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients

Adenocarcinoma | Gastrointestinal Neoplasms | Gastric Cancer | Surgery | Effects of Chemotherapy

Spain
The First Affiliated Hospital with Nanjing Medical...

Enrolling by invitation

Carrelizumab Combined With Concurrent Radiotherapy and Chemotherapy for Unresectable Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

China
Harbin Medical University

Not yet recruiting

Treatment of Rectal Cancer With Long-term Concurrent Chemoradiotherapy Combined With Camrelizumab

Rectal Cancer
Fudan University
The First Affiliated Hospital of Xiamen University; Fujian Province Tumor Hospital

Completed

Concurrent Nimotuzumab Versus Cisplatin With Radiotherapy for Locoregionally Advanced NPC

Nasopharyngeal Carcinoma

China
Sun Yat-sen University
Guangdong Provincial People's Hospital; Affiliated Cancer Hospital of Shantou... and other collaborators

Unknown

A Multicenter Trial Comparing Multi-course Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Guizhou Medical University

Unknown

A Randomized Study of Primary Tumor Radiotherapy for Patients With Stage Ⅳ NSCLC

Radiotherapy | Nonsmall Cell Lung Cancer, Stage IV

China
Royal Marsden NHS Foundation Trust

Unknown

Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks

Digestive System Diseases | Gastrointestinal Diseases | Neoplasms | Neoplasms by Histologic Type | Neoplasms by Site | Adenocarcinoma | Carcinoma | Neoplasms, Glandular and Epithelial | Gastrointestinal Neoplasms | Digestive System Neoplasms | Intestinal Diseases | Colorectal Neoplasms | Intestinal Neoplasms | Rectal... and other conditions

Canada, United Kingdom, Brazil, Cyprus
BeiGene

Completed

Study of Ociperlimab Plus Tislelizumab Plus Chemoradiotherapy in Participants With Untreated Limited-Stage Small Cell Lung Cancer

Limited Stage Small Cell Lung Cancer

China, Korea, Republic of, United States

Search clinical trials for: Concurrent Chemoradiotherapy Radiotherapy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations